Magee is making a world of difference.

One of the keys to Magee’s success is our ability to take ideas from the bench to the bedside quicker and more effectively than other research institutes. Nowhere else do you have the nation’s largest freestanding institute devoted solely to women’s health (Magee-Womens Research Institute) right next door to a world-class women’s hospital (Magee-Womens Hospital). This unique connection allows us to collaborate closely with leading doctors on our clinical trials and treat multiple generations of patients. How our labs are improving lives.

Here are just a few of the ways that Magee is making a difference:

Icon: Our breakthrough non-invasive prenatal testing method is revolutionizing the medical world by making this risky procedure safer for both baby and mom.

Our breakthrough non-invasive prenatal testing method is revolutionizing the medical world by making this risky procedure safer for both baby and mom.

Icon: Preterm birth complicates 1 in 8 U.S. deliveries and accounts for more than 85% of all perinatal morbidity and mortality. Magee researchers have identified a way to prevent preterm birth through the use of the steroid hormone “progesterone”

Preterm birth complicates 1 in 8 U.S. deliveries and accounts for more than 85% of all perinatal morbidity and mortality. Magee researchers have identified a way to prevent preterm birth through the use of the steroid hormone “progesterone”

Icon: Our research on the physiological stress imposed on a woman during pregnancy is leading to new guidelines of care that will reduce the future risk of cardiovascular disease – the leading cause of death
for women.

Our research on the physiological stress imposed on a woman during pregnancy is leading to new guidelines of care that will reduce the future risk of cardiovascular disease – the leading cause of death for women.

Icon: Nearly 30% of all women diagnosed with late-stage ovarian cancer will not live longer than 5 years. Magee is leading the way in developing screening methods using ribonucleic acid (RNA) molecules that can detect ovarian cancer earlier.

Nearly 30% of all women diagnosed with late-stage ovarian cancer will not live longer than 5 years. Magee is leading the way in developing screening methods using ribonucleic acid (RNA) molecules that can detect ovarian cancer earlier.

Icon: Our nationally-recognized study of the placental cells in pregnant mothers is leading to new discoveries that can guard the placenta and other organs against life-threatening viral diseases.

Our nationally-recognized study of the placental cells in pregnant mothers is leading to new discoveries that can guard the placenta and other organs against life-threatening viral diseases.